Russia's Sputnik V vaccine shows 97.2% COVID-19 efficacy in Belarus - RDIF

Reuters, 15.09.2021

MOSCOW, Sept 15 (Reuters) - Russia's Sputnik V vaccine has demonstrated 97.2% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia's RDIF sovereign wealth fund said on Wednesday.

The Russian Direct Investment Fund is marketing the two-shot vaccine abroad.